These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16462060)

  • 1. Physical characteristics of freeze-dried griseofulvin-lipids nanoparticles.
    Kamiya S; Nozawa Y; Miyagishima A; Kurita T; Sadzuka Y; Sonobe T
    Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):181-4. PubMed ID: 16462060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying.
    Kamiya S; Kurita T; Miyagishima A; Itai S; Arakawa M
    Eur J Pharm Biopharm; 2010 Mar; 74(3):461-6. PubMed ID: 20018239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols.
    Kamiya S; Kurita T; Miyagishima A; Arakawa M
    Drug Dev Ind Pharm; 2009 Aug; 35(8):1022-8. PubMed ID: 19466885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.
    Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K
    Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
    Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
    Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions.
    Shekunov BY; Chattopadhyay P; Seitzinger J; Huff R
    Pharm Res; 2006 Jan; 23(1):196-204. PubMed ID: 16307386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical interaction mechanism between nanoparticles and tetrasaccharides (stachyose) during freeze-drying.
    Kamiya S; Nakashima K
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2026-2031. PubMed ID: 28758815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physicochemical interactive mechanism between nanoparticles and raffinose during freeze-drying.
    Kamiya S; Takamatsu H; Sonobe T; Nakashima K
    Int J Pharm; 2014 Apr; 465(1-2):97-101. PubMed ID: 24560638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical characteristics studies.
    Zhang D; Tan T; Gao L; Zhao W; Wang P
    Drug Dev Ind Pharm; 2007 May; 33(5):569-75. PubMed ID: 17520449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
    Shete H; Patravale V
    Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
    Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheological properties of suspensions containing cross-linked starch nanoparticles prepared by spray and vacuum freeze drying methods.
    Shi AM; Li D; Wang LJ; Adhikari B
    Carbohydr Polym; 2012 Nov; 90(4):1732-8. PubMed ID: 22944440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and drying of miconazole and itraconazole nanosuspensions.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying.
    Doktorovova S; Shegokar R; Fernandes L; Martins-Lopes P; Silva AM; Müller RH; Souto EB
    Pharm Dev Technol; 2014 Dec; 19(8):922-9. PubMed ID: 24099511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freeze-drying of composite core-shell nanoparticles.
    Layre AM; Couvreur P; Richard J; Requier D; Eddine Ghermani N; Gref R
    Drug Dev Ind Pharm; 2006 Aug; 32(7):839-46. PubMed ID: 16908421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
    Bozdag S; Dillen K; Vandervoort J; Ludwig A
    J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
    Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
    Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of cyclosporine-loaded poly-sigma-caprolactone nanoparticles.
    Molpeceres J; Aberturas MR; Chacón M; Berges L; Guzmán M
    J Microencapsul; 1997; 14(6):777-87. PubMed ID: 9394259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable sugar-based protein formulations by supercritical fluid drying.
    Jovanović N; Bouchard A; Sutter M; Van Speybroeck M; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
    Int J Pharm; 2008 Jan; 346(1-2):102-8. PubMed ID: 17659851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.